Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2M Buy
107,742
+606
+0.6% +$151K 0.06% 263
2025
Q4
$25.8M Sell
107,136
-54,410
-34% -$13.9M 0.06% 261
2025
Q3
$44.2M Sell
161,546
-27,266
-14% -$7.45M 0.11% 157
2025
Q2
$48.7M Buy
188,812
+85,306
+82% +$20.3M 0.12% 147
2025
Q1
$23.2M Sell
103,506
-36,620
-26% -$8.55M 0.07% 226
2024
Q4
$32M Sell
140,126
-54,475
-28% -$13.1M 0.1% 187
2024
Q3
$47.5M Buy
194,601
+24,221
+14% +$5.41M 0.16% 122
2024
Q2
$32.6M Sell
170,380
-21,485
-11% -$4.36M 0.12% 153
2024
Q1
$38M Buy
+191,865
New +$35.2M 0.12% 160

Other funds holding RMD

Danske Bank's RMD Position: Q1 2026 in Review

Danske Bank increased its ResMed (RMD) stake by 0.57% in Q1 2026, buying an estimated $151K and bringing the position to 107,742 shares worth $24.2M. The position accounts for 0.06% of the portfolio, ranked #263.

Danske Bank first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $48.7M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Danske Bank held 107,742 shares of ResMed worth $24.2M as of Q1 2026.
  • Danske Bank bought 606 ResMed shares in Q1 2026, an estimated $151K.
  • ResMed made up 0.06% of Danske Bank's portfolio in Q1 2026, its #263 holding.
  • Danske Bank first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • Danske Bank's ResMed position peaked at $48.7M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.